The journey towards more accessible, integrated GLP-1 care appears to be gaining momentum
This backflow happens when the lower esophageal sphincter (LES), a ring of muscle at the bottom of the esophagus, does not close properly
There are no large controlled human trials establishing combined efficacy or safety, and the pairing remains a subject of ongoing preclinical interest rather than clinical fact
Liraglutide, lixisenatide, dulaglutide, and semaglutide followed, and the class went on to become one of the most commercially successful in pharmaceutical history, later expanding into obesity
Retrieved from Kobori, T., Onishi, Y., Yoshida, Y., et al
Ozempic is FDA-approved for type 2 diabetes and has product-specific cardiovascular and kidney-risk contexts